Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.35 - $3.28 $878,894 - $8.24 Million
2,511,127 Added 485.59%
3,028,254 $1.06 Million
Q1 2023

May 15, 2023

SELL
$3.28 - $4.81 $1.38 Million - $2.02 Million
-419,344 Reduced 44.78%
517,127 $1.79 Million
Q4 2022

Feb 14, 2023

SELL
$3.65 - $4.82 $32,339 - $42,705
-8,860 Reduced 0.94%
936,471 $4.2 Million
Q3 2022

Nov 14, 2022

SELL
$2.66 - $3.97 $234,010 - $349,256
-87,974 Reduced 8.51%
945,331 $3.44 Million
Q2 2022

Aug 15, 2022

SELL
$2.42 - $4.05 $50,229 - $84,061
-20,756 Reduced 1.97%
1,033,305 $2.74 Million
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $1.91 Million - $3.22 Million
552,296 Added 110.07%
1,054,061 $4.13 Million
Q4 2021

Feb 14, 2022

SELL
$4.89 - $7.59 $197,732 - $306,909
-40,436 Reduced 7.46%
501,765 $2.77 Million
Q3 2021

Nov 15, 2021

BUY
$5.18 - $7.41 $602,646 - $862,086
116,341 Added 27.32%
542,201 $3.91 Million
Q2 2021

Aug 16, 2021

SELL
$3.94 - $6.75 $778,540 - $1.33 Million
-197,599 Reduced 31.69%
425,860 $2.81 Million
Q1 2021

May 17, 2021

BUY
$4.03 - $7.25 $500,598 - $900,580
124,218 Added 24.88%
623,459 $2.71 Million
Q4 2020

Feb 16, 2021

BUY
$2.78 - $4.5 $1.39 Million - $2.25 Million
499,241 New
499,241 $1.91 Million
Q1 2020

May 15, 2020

SELL
$1.35 - $4.05 $309,819 - $929,458
-229,496 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $58,242 - $116,485
-25,323 Reduced 9.94%
229,496 $968,000
Q3 2019

Nov 14, 2019

SELL
$2.9 - $9.56 $1.33 Million - $4.38 Million
-458,359 Reduced 64.27%
254,819 $739,000
Q2 2019

Aug 14, 2019

BUY
$6.7 - $9.13 $3.21 Million - $4.37 Million
478,819 Added 204.31%
713,178 $6.28 Million
Q1 2019

May 15, 2019

BUY
$5.7 - $8.73 $1.34 Million - $2.05 Million
234,359 New
234,359 $1.73 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.